Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target.
Molecules. 2021 Aug 11;26(16):4849. doi: 10.3390/molecules26164849.
Molecules. 2021.
PMID: 34443437
Free PMC article.
Review.